CITADEL ADVISORS LLC

Holdings History for Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

Symbol
CGEM on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
1,988,907 shares
Security Ownership %
3.4%
Shares, Excluding Options vs Price
Value, Excluding Options

Kenneth Griffin ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)

14 Nov 2025 - Kenneth Griffin has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,988,907 shares of Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM). This represents 3.4% ownership of the company. In their previous filing dated 06 Aug 2025, CITADEL ADVISORS LLC had reported owning 3,009,126 shares, indicating a decrease of +34%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.